1083 related articles for article (PubMed ID: 15313942)
1. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
3. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
4. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular assist devices as destination therapy: a new look at survival.
Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
[TBL] [Abstract][Full Text] [Related]
6. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
[TBL] [Abstract][Full Text] [Related]
8. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation.
Gracin N; Johnson MR; Spokas D; Allen J; Bartlett L; Piccione W; Parrillo JE; Costanzo MR; Calvin JE
J Heart Lung Transplant; 1998 Oct; 17(10):1017-23. PubMed ID: 9811411
[TBL] [Abstract][Full Text] [Related]
9. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.
Dembitsky WP; Tector AJ; Park S; Moskowitz AJ; Gelijns AC; Ronan NS; Piccione W; Holman WL; Furukawa S; Weinberg AD; Heatley G; Poirier VL; Damme L; Long JW
Ann Thorac Surg; 2004 Dec; 78(6):2123-9; discussion 2129-30. PubMed ID: 15561049
[TBL] [Abstract][Full Text] [Related]
11. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?
Levy WC; Mozaffarian D; Linker DT; Farrar DJ; Miller LW;
J Heart Lung Transplant; 2009 Mar; 28(3):231-6. PubMed ID: 19285613
[TBL] [Abstract][Full Text] [Related]
12. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
13. Bridge to heart transplantation with left ventricular assist device versus inotropic agents in status 1 patients.
Sasaki H; Mitchell JD; Jessen ME; Lavingia B; Kaiser PA; Comeaux A; Dimaio JM; Meyer DM
J Card Surg; 2009; 24(6):756-62. PubMed ID: 19754680
[TBL] [Abstract][Full Text] [Related]
14. Permanent mechanical circulatory support in patients of advanced age.
Jurmann MJ; Weng Y; Drews T; Pasic M; Hennig E; Hetzer R
Eur J Cardiothorac Surg; 2004 Apr; 25(4):610-8. PubMed ID: 15037280
[TBL] [Abstract][Full Text] [Related]
15. Infection in permanent circulatory support: experience from the REMATCH trial.
Holman WL; Park SJ; Long JW; Weinberg A; Gupta L; Tierney AR; Adamson RM; Watson JD; Raines EP; Couper GS; Pagani FD; Burton NA; Miller LW; Naka Y;
J Heart Lung Transplant; 2004 Dec; 23(12):1359-65. PubMed ID: 15607664
[TBL] [Abstract][Full Text] [Related]
16. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
[TBL] [Abstract][Full Text] [Related]
18. Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device.
Schofield RS; Pierce GL; Nichols WW; Klodell CT; Aranda JM; Pauly DF; Hill JA; Braith RW
Am J Hypertens; 2007 Jun; 20(6):622-8. PubMed ID: 17531918
[TBL] [Abstract][Full Text] [Related]
19. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
[TBL] [Abstract][Full Text] [Related]
20. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
